Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
4th Generation CAR-T Cells for Multiple Myeloma
NCT03778346Phase 1Unknown
- Sponsor
- Lishui People's Hospital
- Start
- Nov 2018
- Primary completion
- Jun 2022
- Countries
- 1
01
Overview
Phase 1, open-label, single-arm trial in multiple myeloma (MM), sponsored by Lishui People's Hospital. Primary endpoint: Adverse events related to treatment at 2 years. Status: unknown.
02
Conditions
multiple myeloma (MM)
Beyond the preview
Go deeper on NCT03778346.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT03778346.